Sign Up to like & get
recommendations!
0
Published in 2020 at "European journal of pharmacology"
DOI: 10.1016/j.ejphar.2020.173503
Abstract: Diabetes mellitus is an increasingly prevalent disease around the globe. The epidemic of diabetes mellitus and its complications pretenses the foremost health threat globally. Diabetic nephropathy is the notable complication in diabetes, leading to end-stage…
read more here.
Keywords:
kidney diseases;
inflammasome promising;
targeting nlrp3;
diabetic nephropathy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Nature Reviews Drug Discovery"
DOI: 10.1038/nrd.2018.149
Abstract: This corrects the article DOI: 10.1038/nrd.2018.97
read more here.
Keywords:
targeting nlrp3;
nlrp3 inflammasome;
inflammatory diseases;
inflammasome inflammatory ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Current medicinal chemistry"
DOI: 10.2174/0929867328666210705153109
Abstract: Diabetic nephropathy (DN) is one of the most common complications of diabetes and the main cause of end-stage renal disease (ESRD). The inflammatory response plays a key role in the pathological process of DN. As…
read more here.
Keywords:
chemistry;
targeting nlrp3;
diabetic nephropathy;
inflammasome diabetic ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23168979
Abstract: Alzheimer’s disease (AD) is the most common cause of dementia in the general population and, to date, constitutes a major therapeutic challenge. In the pathogenesis of AD, aggregates of amyloid β (Aβ) and neurofibrillary tangles…
read more here.
Keywords:
mediated neuroinflammation;
alzheimer disease;
pathology;
targeting nlrp3 ... See more keywords